Stay updated on Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page's revision history now lists Revision: v3.5.3. The previous entry Revision: v3.5.2 is removed from the history listing.
    Difference
    0.0%
    Check dated 2026-04-30T18:57:48.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2 in the page metadata (footer), a technical version change with no impact on study content.
    Difference
    0.0%
    Check dated 2026-04-16T11:15:56.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was deleted in the record history.
    Difference
    0.0%
    Check dated 2026-03-18T19:41:49.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The history now shows Revision: v3.4.3 and removes Revision: v3.4.2. This is a minor version update to the history display.
    Difference
    0.0%
    Check dated 2026-03-11T17:39:35.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    A new version entry was added showing a recruitment status update to the trial record history.
    Difference
    0.0%
    Check dated 2026-02-25T10:17:59.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    The page history now shows a new revision labeled v3.4.2, and the notices about government funding and the older v3.4.1 revision were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T06:21:19.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial page.